Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/301211 stock hub

SHE/301211 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301211is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301211

In the news

Latest news · SHE/301211

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E145.3

P25 23.5P50 41.3P75 83.2

ROE1.5

P25 -0.9P50 4.1P75 8.8

ROIC0.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301211 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

CNY

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	952
Employees Change	-35%
Employees Change Percent	-3.55
Enterprise value	CNY 3.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100005782
Last refreshed	2026-05-10
Market cap	CNY 4.9B
Price	CNY 11.62
Price currency	CNY
Rev Per Employee	482,168.83x
Sector	Healthcare
Sic	2833
Symbol	she/301211
Website	https://www.biocause.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.7%
EV Earnings	98.07x
EV/EBITDA	68.92x
EV/FCF	-72.5x
EV/Sales	7.22x
FCF yield	-0.94%
P/B ratio	2.13x
P/E ratio	145.25x
P/S ratio	10.57x
PE Ratio3 Y	75.9x
PE Ratio5 Y	69.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.04%
EBITDA Margin	10.22%
Gross margin	20.62%
Gross Profit	CNY 94.7M
Gross Profit Growth	-6.37%
Gross Profit Growth Q	-0.92%
Gross Profit Growth3 Y	-17.61%
Gross Profit Growth5 Y	-19.09%
Net Income	CNY 33.8M
Net Income Growth	-47.59%
Net Income Growth Q	-10.73%
Net Income Growth Years	0%
Net Income Growth3 Y	-37.39%
Net Income Growth5 Y	-26.59%
Pretax Margin	8.5%
Profit Margin	7.36%
Profit Per Employee	CNY 35,507
Profitable Years	9
ROA	0
Roa5y	2.2
ROCE	0.01
ROE	1.47
Roe5y	5.39
ROIC	0.11
Roic5y	16.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.18%
Cagr3y	-10.58%
EPS Growth	-45.29
EPS Growth Q	-27.54
EPS Growth Years	0
EPS Growth3 Y	-37.69
EPS Growth5 Y	-30.76
Revenue Growth	8.71x
Revenue Growth Q	5x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-7.5x
Revenue Growth5 Y	-4.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 2.4B
Cash	CNY 1.5B
Current Assets	CNY 1.8B
Current Liabilities	CNY 104.3M
Debt	CNY 2.3M
Debt EBITDA	CNY 0.05
Debt Equity	CNY 0
Debt FCF	CNY -0.05
Equity	CNY 2.3B
Interest Coverage	1.19
Liabilities	CNY 117.6M
Long Term Assets	CNY 607.9M
Long Term Liabilities	CNY 13.3M
Net Cash	CNY 1.5B
Net Cash By Market Cap	CNY 31.69
Net Cash Growth	-4.99%
Net Debt EBITDA	CNY -32.77
Net Debt Equity	CNY -0.67
Tangible Book Value	CNY 2.2B
Tangible Book Value Per Share	CNY 5.31
WACC	7.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.18
Inventory Turnover	2.81
Net Working Capital	CNY 149M
Quick ratio	15.76
Working Capital	CNY 1.7B
Working Capital Turnover	CNY 0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.19%
Dividend Growth	-47.92%
Dividend Growth Years	0%
Dividend per share	CNY 0.06
Dividend Years	4
Dividend Yield	0.52%
Ex Div Date	2025-05-26
Last Dividend	CNY 0.17
Payout Frequency	Annual
Payout Ratio	213%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.18%
200-day SMA	12.87
3Y total return	-28.5%
50-day SMA	12.03
50-day SMA vs 200-day SMA	50under200
All Time High	32.33
All Time High Change	-64.06%
All Time High Date	2022-12-16
All Time Low	9.17
All Time Low Change	26.76%
All Time Low Date	2022-10-11
ATR	0.29
Beta	0.61
Beta1y	0.52
Beta2y	0.61
Ch YTD	-4.91
High	11.68
High52	16.95
High52 Date	2025-11-10
High52ch	-31.45%
Low	11.44
Low52	10.95
Low52 Date	2026-03-23
Low52ch	6.12%
Ma50ch	-3.39%
Price vs 200-day SMA	-9.68%
RSI	44.82
RSI Monthly	45.56
RSI Weekly	41.49
Sharpe ratio	0.23x
Sortino ratio	0.57
Total Return	4.71%
Tr YTD	-4.91
Tr1m	-5.14%
Tr1w	1.13%
Tr3m	-12.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 190,286
Operating Income Growth	-86.58
Operating Income Growth Q	350
Operating Income Growth3 Y	-78.78
Operating Income Growth5 Y	-65.57
Operating margin	0.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,323,100%
Net Borrowing	-1,402,643
Shares Insiders	14.75%
Shares Institutions	0.31%
Shares Out	417,600,000
Shares Qo Q	-5.85%
Shares Yo Y	-4.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -45.7M
Average Volume	3,753,618.05x
Bv Per Share	5.47
CAPEX	CNY -44.8M
Ch1m	-5.14
Ch1w	1.13
Ch1y	3.75
Ch3m	-12.17
Ch3y	-32.29
Ch6m	-18.28
Change	1.66%
Change From Open	0.78
Close	11.43
Days Gap	0.87
Depreciation Amortization	46,730,587
Dollar Volume	50,977,056.2
Earnings Date	2026-07-31
EBIT	CNY 190,286
EBITDA	CNY 46.9M
EPS	CNY 0.08
F Score	4
FCF	CNY -45.7M
FCF EV Yield	-1.38x
FCF Per Share	CNY -0.11
Financing CF	-73,402,643
Fiscal Year End	December
Founded	1,995
Graham Number	3.13659
Graham Upside	-73.01
Income Tax	CNY 5.2M
Investing CF	-1,858,962
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Last Split Date	2025-08-27
Last Split Type	Forward
Lynch Fair Value	CNY 0.4
Lynch Upside	-96.56
Ma150	12.86
Ma150ch	-9.62%
Ma20	11.8
Ma20ch	-1.56%
Net CF	-78,246,923
Next Earnings Date	2026-07-31
Open	11.53
Payment Date	2025-05-26
Position In Range	75
Ppne	524,377,274
Price Date	2026-05-08
Price EBITDA	CNY 103
Ptbv Ratio	2.19
Relative Volume	1.17x
Revenue	459,024,724x
Tax By Revenue	1.13x
Tax Rate	13.35%
Tr6m	-18.28%
Volume	4,387,010
Z Score	28.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301211 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.06 annual per share

Payout ratio

+213.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+4.7%

Next ex-dividend date: 2025-05-26

Performance

SHE/301211 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301211?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+14.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.2%

Negative means the company is buying back shares.

Technical

SHE/301211 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

-9.7%

50/200-day relationship not available

Beta (5Y)

0.61

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301211

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301211 stock rating?

she/301211 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301211 analysis?

The full report lives at /stocks/she/301211/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301211?

The latest report frames she/301211 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301211 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.